Accounting policy
dsm-firmenich classifies ordinary shares and other financial instruments, for which settlement of the contractual obligations is at the sole discretion of dsm-firmenich, as equity.
The price paid for repurchased dsm-firmenich shares (treasury shares) is deducted from dsm-firmenich shareholders’ equity until the shares are reissued. Treasury shares are presented in the treasury share reserve. When treasury shares are sold or reissued, the amount received is recognized as an increase in equity.
Dividend to be distributed to holders of ordinary shares is recognized as a liability when the Annual General Meeting of Shareholders approves the profit appropriation.
|
|
2023 |
|
2022 |
---|---|---|---|---|
Balance at 1 January |
|
10,845 |
|
9,397 |
|
|
|
|
|
Net profit for the year |
|
2,153 |
|
1,715 |
Other comprehensive income |
|
30 |
|
227 |
Options/share units granted |
|
23 |
|
34 |
Dividend |
|
(582) |
|
(459) |
Proceeds from issuance of new ordinary shares |
|
11,510 |
|
- |
Expenditures related to issuance of new shares |
|
(29) |
|
- |
Proceeds from reissue of ordinary shares |
|
24 |
|
141 |
Acquisition of NCI without a change in control |
|
48 |
|
- |
Acquisition (divestment) of subsidiary with NCI |
|
(4) |
|
(4) |
Repurchase of shares |
|
(256) |
|
(210) |
Liability i.r.t. buy-out non-tendered shares DSM N.V. |
|
(649) |
|
- |
Other changes |
|
(43) |
|
4 |
Balance at 31 December |
|
23,070 |
|
10,845 |
Share capital
On 31 December 2023, the capital amounted to €2.7 million, consisting of 265.7 million ordinary shares. All DSM-Firmenich AG shares have a nominal value of €0.01 each. The outstanding shares provide an entitlement of one vote per share at the General Meeting of Shareholders. All rights attached to the company’s shares held by the Group (treasury shares) are suspended until those shares are reissued.
|
|
Date of issuance |
|
Quantity |
|
Issue price/ |
|
Nominal value1 (in € million) |
|
Share premium (in € million) |
|
Total issuance value (in € million) |
||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DSM N.V. shares swapped into dsm-firmenich shares – 1st offer period |
|
20 April 2023 |
|
150,742,711 |
|
|
|
|
|
|
|
|
||||
DSM N.V. shares swapped into dsm-firmenich shares – 2nd offer period |
|
3 May 2023 |
|
16,578,846 |
|
|
|
|
|
|
|
|
||||
Issued dsm-firmenich shares – compensate for non-tendered shares DSM N.V. |
|
8 May 2023 |
|
6,696,477 |
|
109.50 |
|
0 |
|
733 |
|
733 |
||||
Issued dsm-firmenich shares – issued to shareholders Firmenich International SA |
|
8 May 2023 |
|
91,658,354 |
|
117.58 |
|
1 |
|
10,776 |
|
10,777 |
||||
Total |
|
|
|
|
|
|
|
|
|
|
|
11,510 |
||||
|
In 2023, a total of 167.3 million DSM N.V. shares were exchanged for DSM-Firmenich AG shares (ratio 1:1), 6.7 million new shares were issued and placed in the stock market, and 91.7 million DSM-Firmenich AG new shares were granted to the former Firmenich owners. All shares issued are fully paid.
A number of 6.7 million DSM N.V. shares were not tendered; the company has commenced a statutory buy-out procedure to acquire these shares, and recognized a liability of €649 million at the end of the reporting period.
Prior to the merger, Koninklijke DSM N.V. was the parent of the Group. The changes in the number of issued and outstanding shares in 2022 and 2023 until 8 May are shown in the following table.
|
|
Issued shares |
|
Treasury shares |
|
Treasury shares |
---|---|---|---|---|---|---|
|
|
Ordinary |
|
Cumprefs A |
|
Ordinary |
Balance at 1 January 2022 |
|
174,786,029 |
|
44,040,000 |
|
1,817,299 |
|
|
|
|
|
|
|
Reissue of shares in connection with share‑based payments |
|
|
|
|
|
(617,967) |
Repurchase of shares |
|
|
|
|
|
1,330,000 |
Dividend in the form of ordinary shares |
|
|
|
|
|
(818,700) |
Balance at 31 December 2022 |
|
174,786,029 |
|
44,040,000 |
|
1,710,632 |
|
|
|
|
|
|
|
Number of treasury shares at 31 December 2022 |
|
(1,710,632) |
|
|
|
|
Number of shares outstanding at 31 December 2022 |
|
173,075,397 |
|
44,040,000 |
|
|
|
|
|
|
|
|
|
Balance at 1 January 2023 |
|
174,786,029 |
|
44,040,000 |
|
1,710,632 |
|
|
|
|
|
|
|
Reissue of shares in connection with share‑based payments |
|
|
|
|
|
(280,021) |
Shares DSM N.V. swapped to DSM-Firmenich AG shares |
|
(167,321,557) |
|
|
|
(662,616) |
Cancellation of shares |
|
(767,995) |
|
(44,040,000) |
|
(767,995) |
Non-tendered shares recognized as liability |
|
(6,696,477) |
|
|
|
|
Balance at 31 December 2023 |
|
- |
|
- |
|
- |
On 28 April 2023, 44.0 million outstanding Cumulative preference shares A Koninklijke DSM N.V. were repurchased for the amount of €256 million. On 31 May 2023, all Cumulative preference shares A and C were canceled.
As of the completion of the merger, DSM-Firmenich AG is the new parent of the Group. The changes in the number of issued and outstanding shares starting 8 May are shown in the following table.
|
|
Issued shares |
|
Treasury shares |
---|---|---|---|---|
|
|
Ordinary |
|
Ordinary |
Balance at 1 January 2023 |
|
- |
|
- |
|
|
|
|
|
Issue of new shares via tender process |
|
167,321,557 |
|
|
Issue of new shares via placement in the market |
|
98,354,831 |
|
|
Swap treasury shares DSM N.V. to DSM-Firmenich AG |
|
|
|
662,616 |
Reissue of shares in connection with share-based payments |
|
|
|
(270,044) |
Balance at 31 December 2023 |
|
265,676,388 |
|
392,572 |
|
|
|
|
|
Number of treasury shares at 31 December 2023 |
|
(392,572) |
|
|
Number of shares outstanding at 31 December 2023 |
|
265,283,816 |
|
|
Share premium
The share premium increased by €11,260 million mainly due to the issuance of new shares (€11,758 million), partly offset by the dividend distribution out of share premium on 6 July 2023 of €425 million by DSM-Firmenich AG.
Treasury shares
In 2023, the Group did not repurchase own shares to fulfill its obligations under the share-based compensation plans. At 31 December 2023, dsm-firmenich possessed 0.4 million ordinary shares, or 0.15% of the share capital, for servicing share-option rights and share plans. The average purchase price of the ordinary treasury shares as at 31 December 2023 was €112.34.
Other reserves in Shareholders’ equity
|
|
Translation reserve |
|
Hedging reserve |
|
Reserve for share-based compensation |
|
Fair value reserve |
|
Total |
---|---|---|---|---|---|---|---|---|---|---|
Balance at 1 January 2022 |
|
177 |
|
(77) |
|
39 |
|
17 |
|
156 |
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
Fair-value changes of derivatives |
|
- |
|
(6) |
|
- |
|
- |
|
(6) |
Release to income statement |
|
(16) |
|
53 |
|
- |
|
- |
|
37 |
Fair-value changes of other financial assets |
|
- |
|
- |
|
- |
|
(61) |
|
(61) |
Exchange differences |
|
267 |
|
- |
|
- |
|
- |
|
267 |
Options and performance shares granted |
|
- |
|
- |
|
34 |
|
- |
|
34 |
Options and performance shares exercised/canceled |
|
- |
|
- |
|
(29) |
|
- |
|
(29) |
Transfer to retained earnings |
|
- |
|
- |
|
- |
|
(28) |
|
(28) |
Income tax |
|
(4) |
|
(3) |
|
- |
|
- |
|
(7) |
Total changes |
|
247 |
|
44 |
|
5 |
|
(89) |
|
207 |
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December 2022 |
|
424 |
|
(33) |
|
44 |
|
(72) |
|
363 |
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
Fair-value changes of derivatives |
|
- |
|
34 |
|
- |
|
- |
|
34 |
Release to income statement |
|
6 |
|
(7) |
|
- |
|
- |
|
(1) |
Fair-value changes of other financial assets |
|
- |
|
- |
|
- |
|
(65) |
|
(65) |
Exchange differences |
|
144 |
|
- |
|
- |
|
- |
|
144 |
Options and performance shares granted |
|
- |
|
- |
|
23 |
|
- |
|
23 |
Options and performance shares exercised/canceled |
|
- |
|
- |
|
(23) |
|
- |
|
(23) |
Transfer to retained earnings |
|
- |
|
- |
|
- |
|
(5) |
|
(5) |
Income tax |
|
- |
|
(1) |
|
- |
|
5 |
|
4 |
Total changes |
|
150 |
|
26 |
|
- |
|
(65) |
|
111 |
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December 2023 |
|
574 |
|
(7) |
|
44 |
|
(137) |
|
474 |
The increase in the Translation reserve in 2023 is mainly caused by a weakening of the euro against the Swiss franc versus a strengthening against the US dollar and Chinese renminbi. As a consequence, the total value of the subsidiaries increased, which led to a positive exchange difference of €144 million.
Additional information on the reserves is provided in Note 6 Share capital to the Parent company financial statements.
Dividend
Prior to the merger, dividend was paid to the holders of cumulative preference shares A and of non-tendered ordinary shares of Koninklijke DSM N.V. In the subsequent period, the Group paid a dividend to the holders of ordinary shares of DSM-Firmenich AG.
|
|
2023 |
|
2022 |
---|---|---|---|---|
Shareholders Koninklijke DSM N.V. |
|
|
|
|
Per cumulative preference share A: €0.14 (2022: €0.13) |
|
6 |
|
6 |
Interim dividend ordinary shares: (2022: 0.93) |
|
- |
|
161 |
Final dividend ordinary shares: €22.58 (2022: €1.70) |
|
151 |
|
292 |
|
|
|
|
|
Shareholders DSM-Firmenich AG |
|
|
|
|
Per ordinary share: €1.60 |
|
425 |
|
|
Total |
|
582 |
|
459 |
Deeply subordinated fixed rate resettable perpetual notes
Firmenich International SA issued deeply subordinated fixed rate resettable perpetual notes for the amount of €750 million on 3 June 2020 with a coupon of 3.75% payable annually at the sole discretion of the issuer until the first reset date i.e. 3 September 2025. Thereafter, the interest rate is reset every 5 years. In 2023, the remuneration on the deeply subordinated fixed rate resettable perpetual notes amounts to €28 million. In accordance with the provisions of IAS 32 Financial Instruments – Presentation, this instrument is accounted for in equity.